Firibastat

N/A

Report date: 2022/09/02 12:54:00
NME

Base Information

Drug NameFiribastat
Drug Alias NameAmino butane sulfonate disulfureRB-150QGC-001QGC-011QGC-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamyl aminopeptidase inhibitors
TargetsGlutamyl aminopeptidase
Therapy Area/IndicationsEssential HypertensionHypertensionMyocardial Infarction +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[12
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesQuantum Genomics Sa
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHypertensionMyocardial Infarction
Inactive IndicationsEssential HypertensionHeart FailureRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A